117 related articles for article (PubMed ID: 49550)
1. Letter: Second malignancies in treated Hodgkin's patients and splenectomy.
Papaioannou A
Lancet; 1975 Jun; 1(7920):1346-7. PubMed ID: 49550
[No Abstract] [Full Text] [Related]
2. Splenectomy in Hodgkin's disease and second leukaemias.
van Leeuwen FE; Somers R; Hart AA
Lancet; 1987 Jul; 2(8552):210-1. PubMed ID: 2885655
[No Abstract] [Full Text] [Related]
3. Risk of new cancers in patients with Hodgkin's disease.
Arseneau JC; Canellos GP; Johnson R; DeVita VT
Cancer; 1977 Oct; 40(4 Suppl):1912-6. PubMed ID: 907993
[No Abstract] [Full Text] [Related]
4. Concomitant illness in patients treated for Hodgkin's disease.
Bookman MA; Longo DL
Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412
[No Abstract] [Full Text] [Related]
5. Leukemia following Hodgkin's disease.
Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
[TBL] [Abstract][Full Text] [Related]
6. Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy.
Swerdlow AJ; Douglas AJ; Vaughan Hudson G; Vaughan Hudson B; MacLennan KA
Br J Cancer; 1993 Nov; 68(5):1006-11. PubMed ID: 8217588
[TBL] [Abstract][Full Text] [Related]
7. Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
Sutherland RM; McCredie JA; Inch WR
Clin Oncol; 1975 Dec; 1(4):275-84. PubMed ID: 1082407
[No Abstract] [Full Text] [Related]
8. [Second tumors following treatment of Hodgkin's disease].
Somers R; van Leeuwen FE; Taal BG; van Heerde P; Coster B; Hart AA
Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1358-62. PubMed ID: 3412505
[No Abstract] [Full Text] [Related]
9. Second malignancy complicating Hodgkin's disease.
Tawil E; Mercier JP
J Can Assoc Radiol; 1983 Jun; 34(2):108-13. PubMed ID: 6688422
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
11. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease in children.
Pao WJ; Kun LE
Hematol Oncol Clin North Am; 1989 Jun; 3(2):345-65. PubMed ID: 2663832
[TBL] [Abstract][Full Text] [Related]
13. [Herpes zoster in children treated for Hodgkin's disease].
Armata J; Balwierz W; Rytlewska M
Pol Tyg Lek; 1984 May; 39(21):701-3. PubMed ID: 6483673
[No Abstract] [Full Text] [Related]
14. [Explorative laparotomy and splenectomy in Hodgkin's disease].
Fischer J
Hamatol Bluttransfus; 1976; 18():89-97. PubMed ID: 964718
[No Abstract] [Full Text] [Related]
15. [The spleen and Hodgkin's disease].
Athanasiu A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(4):207-306. PubMed ID: 22909
[No Abstract] [Full Text] [Related]
16. Solid tumors complicating Hodgkin's disease. A report on two patients with immunoglobulin deficiency.
O'Sullivan DD; Raghuprasad P; Ezdinli EZ
Arch Intern Med; 1979 Oct; 139(10):1134-4. PubMed ID: 485745
[TBL] [Abstract][Full Text] [Related]
17. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
Pappas A; Pees H; Girmann G
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
[TBL] [Abstract][Full Text] [Related]
18. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
[TBL] [Abstract][Full Text] [Related]
19. Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
Sargur M; Buckner CD; Appelbaum FR; Stewart P; Deeg HJ; Weiden PL; Sullivan KM; Fefer A; Thomas ED
J Clin Oncol; 1987 May; 5(5):731-4. PubMed ID: 3553436
[TBL] [Abstract][Full Text] [Related]
20. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
